Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2024

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended				Six months ended
	June 30,				June 30,
	2024		2023		2024		2023
	(in thousands)
Insurance carriers	$	384,128	$	226,521	$	725,156	$	436,899
Laboratory and other partners		22,254		27,449		42,530		50,254
Patients		6,969		7,434		13,406		16,007
Total revenues	$	413,351	$	261,404	$	781,092	$	503,160

Schedule of total revenue by geographic area

	Three months ended				Six months ended
	June 30,				June 30,
	2024		2023		2024		2023
	(in thousands)
United States	$	404,872	$	253,296	$	764,285	$	486,550
Americas, excluding U.S.		1,601		1,206		3,082		2,364
Europe, Middle East, India, Africa		5,439		5,620		10,617		10,816
Asia Pacific and Other		1,439		1,282		3,108		3,430
Total revenues	$	413,351	$	261,404	$	781,092	$	503,160

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at
	June 30,		December 31,
	2024		2023
	(in thousands)
Assets:
Accounts receivable, net	$	335,936	$	278,289
Liabilities:
Deferred revenue, current portion	$	18,367	$	16,612
Deferred revenue, long-term portion		18,416		19,128
Total deferred revenues	$	36,783	$	35,740

Schedule of changes in the balance of deferred revenues

	Balance at
	June 30,
	2024			2023
	(in thousands)
Beginning balance	$	35,740	$	30,778
Increase in deferred revenues		14,826		17,402
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(9,646)		(7,521)
Revenue recognized from performance obligations satisfied within the same period		(4,137)		(3,513)
Ending balance	$	36,783	$	37,146